IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Darwin Global Management, Ltd.

Q3 2021 Holdings

Filed 2021-11-15 | 12 holdings | $55.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biontech SE(BNTX)SPONSORED ADS09075V102$36.3M132,93265.7%
Bridgebio Pharma Inc(BBIO)COM10806X102$11.9M253,69221.5%
Adagio Therapeutics Inc(IVVD)COM00534A102$3.7M86,5286.6%
Aclaris Therapeutics Inc(ACRS)COM00461U105$2.9M159,3935.2%
Acceleron Pharma Inc(XLRN)COM00434H108$344.2K2,000,0000.6%
Intellia Therapeutics Inc(NTLA)COM45826J105$100.9K752,0240.2%
Fate Therapeutics Inc(FATE)COM31189P102$20.9K353,2500.0%
Inhibrx Inc(INBXUSD)COM45720L107$18.1K542,5860.0%
VIR Biotechnology Inc(VIR)COM92764N102$2.0K45,3110.0%
Verve Therapeutics IncCOM92539P101$1.3K27,3970.0%
Fulcrum Therapeutics Inc(FULC)COM359616109$95933,9970.0%
Aerovate Therapeutics IncCOM008064107$26212,4840.0%